As of 2026-07-13, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 16.9x | 16.0x |
| Forward P/E multiples | 15.0x - 21.0x | 17.9x |
| Fair Price | (1,009.48) - (1,139.53) | (1,141.25) |
| Upside | -4211.9% - -4741.7% | -4748.7% |
| Date | EV/EBITDA |